Assessment of the impact of new UK guidelines on the management of aromatase inhibitor-associated bone loss.
Sowden
E
E
Evans
B
B
Greenbank
C M
CM
Bukhari
M
M
Halsey
J P
JP
D000328:Adult; D000368:Aged; D047072:Aromatase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D004164:Diphosphonates / Q000191:economics / Q000627:therapeutic use*; D005260:Female; D019983:Guideline Adherence; D017408:Guidelines as Topic; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced / Q000191:economics / Q000517:prevention & control*; D006113:United Kingdom
D047072:Aromatase Inhibitors; D004164:Diphosphonates